Sulphonylureas and hypoglycaemia.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMC 2545428)

Published in Br Med J (Clin Res Ed) on April 02, 1988

Authors

R E Ferner1, H A Neil

Author Affiliations

1: Wolfson Unit of Clinical Pharmacology, Royal Victoria Infirmary, Newcastle upon Tyne.

Articles cited by this

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes (1970) 4.57

Factors contributing to deaths of diabetics under fifty years of age. On behalf of the Medical Services Study Group and British Diabetic Association. Lancet (1981) 3.60

Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia (1983) 2.06

The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabet Med (1988) 2.03

Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? Br Med J (Clin Res Ed) (1982) 1.91

Can insulin-treated diabetics be given beta-adrenergic blocking drugs? Br Med J (1980) 1.52

Hypoglycaemia. Clin Endocrinol Metab (1980) 1.49

Severe hypoglycemia in diabetic patients: frequency, causes, prevention. Diabetes Care (1985) 1.37

Drug-induced hypoglycemia. A review based on 473 cases. Diabetes (1972) 1.35

Metformin and glibenclamide: comparative risks. Br Med J (Clin Res Ed) (1984) 1.15

Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics. Lancet (1975) 1.15

The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs. Clin Pharmacokinet (1987) 1.01

Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay. Diabetologia (1982) 1.00

The control of 86Rb efflux from rat isolated pancreatic islets by the sulphonylureas tolbutamide and glibenclamide. Br J Pharmacol (1984) 0.99

Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care (1985) 0.98

Glibenclamide induced prolonged hypoglycaemia. Age Ageing (1986) 0.96

Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets. Acta Endocrinol (Copenh) (1984) 0.91

On the use of a new somatostatin analogue in the treatment of hypoglycaemia in patients with insulinoma. Clin Endocrinol (Oxf) (1986) 0.90

Plasma levels of glibenclamide in diabetic patients during its routine clinical administration determined by a specific radioimmunoassay. Horm Metab Res (1983) 0.89

Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics. Clin Pharmacol Ther (1983) 0.88

Chlorpropamide-induced hypoglycemia: successful treatment with diazoxide. Am J Med (1977) 0.85

[The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984]. Schweiz Med Wochenschr (1986) 0.82

Studies in patients with chlorpropamide-induced hypoglycemia. Diabetes (1970) 0.80

Need for glucagon in severe hypoglycaemia induced by sulphonylurea drugs. Lancet (1967) 0.79

Management of chlorpropamide-induced hypoglycemia with diazoxide. South Med J (1978) 0.79

[Hypoglycemia during treatment with sulfonylurea preparations]. Ugeskr Laeger (1986) 0.78

Articles by these authors

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ (2000) 10.66

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ (1998) 7.48

Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. BMJ (1998) 3.07

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group. Diabet Med (2000) 2.20

Drugs in donated blood. Lancet (1989) 1.97

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Health Technol Assess (2000) 1.80

Approach to maintaining comparability of biochemical data during long-term clinical trials. Clin Chem (1997) 1.70

Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study. The Oxford Myocardial Infarction Incidence Study Group. Heart (1998) 1.58

Biometry of the crystalline lens in early-onset diabetes. Br J Ophthalmol (1990) 1.47

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease. BMJ (1993) 1.38

A meta-analysis of the effect of garlic on blood pressure. J Hypertens (1994) 1.17

Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. The Oxford Regional Prospective Study Group. Diabet Med (2000) 1.14

Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Diabetes Care (2001) 1.01

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47). Am Heart J (1999) 0.99

Cerebral blood flow increases during insulin-induced hypoglycaemia in type 1 (insulin-dependent) diabetic patients and control subjects. Diabetologia (1987) 0.98

Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes. Diabetes Care (2000) 0.96

The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus. Diabetologia (1999) 0.92

Autofluorescence of the crystalline lens in early and late onset diabetes. Br J Ophthalmol (1992) 0.91

Nutritional research in World War 2: the Oxford Nutrition Survey and its research potential 50 years later. Br J Nutr (2000) 0.90

Assessing the impact of blood sample type on the estimated prevalence of impaired glucose tolerance and diabetes mellitus in epidemiological surveys. Diabet Med (1995) 0.87

Patient-related outcomes five years after coronary artery bypass graft surgery. QJM (1999) 0.87

Patients undergoing coronary artery bypass graft surgery are at high risk of impaired glucose tolerance and diabetes mellitus during the first postoperative year. Metabolism (1995) 0.86

Biometry of the crystalline lens in late onset diabetes: the importance of diabetic type. Br J Ophthalmol (1992) 0.85

Markers of renal tubular dysfunction measured annually do not predict risk of microalbuminuria in the first few years after diagnosis of Type I diabetes. Diabetologia (2001) 0.84

Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures. Diabetes Res Clin Pract (1994) 0.84

Lens opacity and mortality in diabetes. Diabet Med (1990) 0.84

Diabetes mellitus: attitudes, knowledge and glycaemic control in a cross-sectional population. J R Coll Gen Pract (1988) 0.83

Impaired beta-cell responses improve when fasting blood glucose concentration is reduced in non-insulin-dependent diabetes. Q J Med (1988) 0.82

Is risk of diabetes mellitus increased after abdominal radiotherapy? Lancet (1996) 0.82

Segregation analysis of NIDDM in Caucasian families. Diabetologia (1994) 0.81

A population-based study of the incidence of complications associated with type 2 diabetes in the elderly. Diabet Med (1991) 0.81

Risk of hypothermia in elderly patients with diabetes. Br Med J (Clin Res Ed) (1986) 0.81

Prognostic value of urinary albumin concentration in diabetic patients surviving the first 5 years after assessment. Diabetologia (1994) 0.79

A pilot study of garlic consumption shows no significant effect on markers of oxidation or sub-fraction composition of low-density lipoprotein including lipoprotein(a) after allowance for non-compliance and the placebo effect. Clin Chim Acta (1999) 0.79

Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery. Heart (1997) 0.79

Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. Arterioscler Thromb (1994) 0.78

High apolipoprotein AI concentrations are associated with lower mortality and myocardial infarction five years after coronary artery bypass graft surgery. Heart (1999) 0.76

Autonomic neuropathy in type II diabetes mellitus: the influence of obesity. J Intern Med (1990) 0.75

Biometry and auto-fluorescence of the anterior ocular segment in diabetics with and without autonomic neuropathy: a case control study. Eye (Lond) (1992) 0.75

A suitable case for treatment. Lancet (1995) 0.75

The management of hyperlipidaemia: are specialist lipid clinics needed? J R Coll Physicians Lond (1992) 0.75

Compact: a computer package for clinical trials. Diabet Med (1988) 0.75

Relation between insulinemia, body mass index, and lipoprotein composition in healthy, nondiabetic men and women. Arterioscler Thromb (1992) 0.75